Skip to main content

Table 2 A summary of several aptamers developed for the treatment of viral infections by SELEX method

From: Therapeutic applications of nucleic acid aptamers in microbial infections

Organism

Type of aptamer

Target

Aptamer therapeutic effect

Ref

HBV

DNA

Core protein

-Prevent the assembly of the nucleocapsid

-function by suppressing HBV replication

[82]

HCV

DNA

Envelope Protein

-Inhibition of virus binding to host cells

[90]

Influenza A virus

DNA

Hemagglutinin protein

-Blocking the binding of

virus to target cell receptors

-prevention of the virus invasion into the host cells

[83]

Ebola Virus

RNA

VP35

-Disrupt the eVP35− NP interaction

[91]

HIV-1

RNA

gag protein

-Inhibit HIV-1 replication

[92]

HSV-1

RNA

gD protein

-Blocking the gD functions

[85]

Vaccinia virus

DNA

Hemagglutinin protein

-Recognize proteins

expressed on the surface of VV- infected cells

[93]

Influenza B Virus

RNA

Hemagglutinin protein

-Inhibited HA-mediated membrane fusion

[94]

SCV

RNA

nsP10

-Inhibit double-stranded DNA unwinding activity of the helicase

[89]

Rabies virus

DNA

Blocking the interaction

between rabies virus and permissive host cell receptors

-Reduced viral replication in an in vitro infection model

[84]

  1. VP35 viral protein 35, NP nucleoprotein, nsP10 NTPase/Helicase